Posts Tagged ‘VVUS’

Vivus Call ‘Fly In Play


Today’s tickers: VVUS, NUS & RHT

VVUS - Vivus, Inc. – A large options trade on Vivus, Inc. appears to be a directional bet on the biotech company’s shares ahead of impending recommendations from an advisory panel, as well as a possible decision from FDA regulators, on whether to approve obesity drug, Qnexa. Shares in VVUS are down 1.5% today at $20.06. The large call butterfly spread purchased on Vivus in the first half of the trading day yields maximum possible gains in the event that shares soar more than 50.0% in the next three weeks. The options player responsible for the single largest trade in the name today appears to have purchased 3,250 calls at the April $27 and $35 strikes, and sold 6,500 calls at the April $31 strike, all for a net premium of $0.55 per contract. Profits on the call ‘fly kick in if shares in VVUS rally at least 37.3% to surpass the breakeven share price of $27.55, while the maximum potential payoff of $3.45 per contract is available to the trader as long as the stock jumps 54.5% to settle at $31.00 at expiration next month. The strategist stands to lose the full amount of premium paid to establish the spread if shares settle below $27.00 or above $35.00. A decision from regulators is expected by April 17th, three days prior to options expiration.

NUS - Nu Skin Enterprises, Inc. – Bearish activity in Nu Skin Enterprises, Inc. options is on the rise this morning with shares in the maker of anti-aging skin products and other personal care items trading down 4.4% at $56.85 as of 11:15 a.m. in New York. Traders picking up $55 strike put options in April and May today appear to be positioning for the price of the…
continue reading


Tags: , ,




Options Player Positions for Recovery in Beleaguered Bank of America Shares

Today’s tickers: BAC, JNJ, EXP, KO, YHOO, VVUS, SKS & STJ

BAC – Bank of America Corp. – A large-volume bullish risk reversal initiated in the September contract on Bank of America in the first half of the current trading day indicates one options strategist is positioning for a rebound in the price of the underlying stock by expiration day in a couple of months. BAC’s shares, which fell 2.85% to $13.38 this afternoon, are currently down more than 32.7% since the stock reached a 52-week high of $19.86 back on April 15, 2010. Analysts at Goldman Sachs removed Bank of America from the conviction buy list on Monday. But, one optimistic individual is rooting for BAC to come roaring back to life by September expiration day. The investor appears to have sold 20,000 puts at the September $12 strike for a premium of $0.26 apiece in order to purchase the same number of calls at the higher September $15 strike for a premium of $0.36 each. The net cost of the transaction amounts to $0.10 per contract. If financial services firm’s shares fail to rally above $15.00 by expiration, the investor will lose the full premium paid to purchase the trade. However, if the price of the underlying increases 12.85% over the current price of $13.38, the risk reversal player will start to make money above the effective breakeven price of $15.10 through September expiration. Finally, the short position in put options at the September $12 strike suggests the investor is willing to have Bank of America shares put to him at an effective price of $12.10 apiece should the puts land in-the-money at expiration.

JNJ – Johnson & Johnson – Shares of the provider of consumer products, pharmaceuticals and medical devices fell more than 2.85% in afternoon trading to arrive at $56.89 just before 3:00 pm (ET). The health care company’s shares slipped lower after the firm said second-quarter revenue was flat and lowered its 2010 profit forecast by $0.15 a share. JNJ still reported a 7.5% increase in net income, earning $1.23 a share in the second-quarter, but revising full year earnings lower took its toll on the price of the underlying stock today. One contrarian options player populating JNJ LEAPS caught our eye this afternoon. The investor appears to have purchased a plain-vanilla debit call spread using sky-high strike prices in the January 2012 contract. The…
continue reading


Tags: , , , , , , ,




Call Options on Financials ETF (XLF) in High Demand

Today’s tickers: XLF, MOS, RIMM, F, VVUS, WEN & ALTR

XLF – Financial Select Sector SPDR – Near-term bullish bets that shares of the XLF, an exchange-traded fund designed to provide investment results that correspond to the price and yield performance of the Financial Select Sector of the S&P 500 Index, are set to rally ahead of July expiration jumped during afternoon trading. Shares of the ETF increased nearly 1.5% during the session to stand at $14.52 by 3:15 pm (ET). Options investors itching for a rally in the price of the underlying shares purchased at least 115,000 calls outright at the July $15 strike for an average premium of $0.08 per contract. Call buyers are prepared to profit should shares of the XLF gain 3.85% to trade above the average breakeven price of $15.08 by expiration next Friday.

MOS – The Mosaic Co. – Shares of the producer and marketer of concentrated phosphate and potash crop nutrients are up 3.3% to $46.20 with less than 45 minutes remaining ahead of the closing bell. Mosaic’s shares earlier rallied as much as 3.95% to touch an intraday high of $46.49. One bullish strategist purchased a debit call spread on the stock in order to position for Mosaic’s shares to increase substantially by expiration day in September. The trader picked up 2,800 calls at the September $50 strike for an average premium of $1.99 apiece, and sold the same number of calls at the higher September $65 strike for an average premium of $0.07 each. Net premium paid for the spread amounts to $1.92 per contract. The investor responsible for the transaction makes money as long as the potash producer’s shares surge 12.4% in the next several months to exceed the average breakeven point on the spread at $51.92 by expiration. Maximum available profits of $13.08 per contract pad the investor’s wallet if MOS shares jump 39.8% to trade above $65.00 by expiration day in September. Mosaic’s shares last traded above $65.00 back on January 11, 2010, when the stock reached an intraday and new 52-week high of $68.28.

RIMM – Research in Motion Ltd. – News the Blackberry maker plans to start an applications store as well as consumer Internet services in China sent RIMM’s shares up 8.47% in afternoon trading to an intraday high of $53.65 by 3:25 pm (ET). Optimism on the firm’s expansion in the Chinese market was…
continue reading


Tags: , , , , , ,




 
 
 

Phil's Favorites

Why do people believe con artists?

 

Why do people believe con artists?

Would you buy medicine from this man? Carol M. Highsmith/Wikimedia Commons

Courtesy of Barry M. Mitnick, University of Pittsburgh

What is real can seem pretty arbitrary. It’s easy to be fooled by misinformation disguised as news and deepfake videos showing people doing things they never did or said. Inaccurate information – even deliberately wrong informatio...



more from Ilene

Members' Corner

Why do people believe con artists?

 

Why do people believe con artists?

Would you buy medicine from this man? Carol M. Highsmith/Wikimedia Commons

Courtesy of Barry M. Mitnick, University of Pittsburgh

What is real can seem pretty arbitrary. It’s easy to be fooled by misinformation disguised as news and deepfake videos showing people doing things they never did or said. Inaccurate information – even deliberately wrong informatio...



more from Our Members

Zero Hedge

Easily Overlooked Issues Regarding COVID-19

Courtesy of ZeroHedge View original post here.

Authored by Gail Tverberg via Our Finite World,

We read a lot in the news about the new Wuhan coronavirus and the illness it causes (COVID-19), but some important points often get left out.

[1] COVID-19 is incredibly contagious.

COVID-19 transmits extremely easily from person to person. Interpersonal contact doesn’t need to be...



more from Tyler

The Technical Traders

Gold Rallies As Fear Take Center Stage

Courtesy of Technical Traders

Gold has rallied extensively from the lows near $1560 over the past 2 weeks.  At first, this rally didn’t catch too much attention with traders, but now the rally has reached new highs above $1613 and may attempt a move above $1750 as metals continue to reflect the fear in the global markets.

We’ve been warning our friends and followers of the real potential in precious metals for many months – actually since early 2018.  Our predictive modeling system suggests Gold will rally above $1650 very quickly, then possibly stall a bit before continuing higher to target the $1750 range.

The one thing all skilled traders must consider is the longer-term fear that is build...



more from Tech. Traders

Kimble Charting Solutions

Precious Metals Eyeing Breakout Despite US Dollar Strength

Courtesy of Chris Kimble

Gold and silver prices have been on the rise in early 2020 as investors turn to precious metals as geopolitical concerns and news of coronavirus hit the airwaves.

The rally in gold has been impressive, with prices surging past $1600 this week (note silver is nearing $18.50).

What’s been particularly impressive about the Gold rally is that it has unfolded despite strength in the US Dollar.

In today’s chart, we look at the ratio of Gold to the US Dollar Index. As you can see, this ratio has traded in a rising channel over the past 4 years.

The Gold/US Dollar ratio is currently attempting a breakout of this rising channel at (1).

This would come on further ...



more from Kimble C.S.

Insider Scoop

68 Stocks Moving In Friday's Mid-Day Session

Courtesy of Benzinga

Gainers
  • Trans World Entertainment Corporation (NASDAQ: TWMC) shares climbed 120.5% to $7.72 after the company disclosed that its subsidiary etailz entered into a deal with Encina for $25 million 3-year secured revolving credit facility.
  • Celldex Therapeutics, Inc. (NASDAQ: CLDX) fell 39.8% to $3.1744. Cantor Fitzgerald initiated coverage on Celldex Therapeutics with an Overweight rating and a $8 price target.
  • TSR, Inc. (NASDAQ: TSRI) gained 36.2% to $8.17.
  • ...


http://www.insidercow.com/ more from Insider

Biotech & Health

Deep learning AI discovers surprising new antibiotics

 

Deep learning AI discovers surprising new antibiotics

A colored electron microscope image of MRSA. NIH - NIAID/flickr, CC BY

Courtesy of Sriram Chandrasekaran, University of Michigan

Imagine you’re a fossil hunter. You spend months in the heat of Arizona digging up bones only to find that what you’ve uncovered is from a previously discovered dinosaur.

That’s how the search for antibiotics has panned out recently. The relatively few antibiotic hunters out there ...



more from Biotech

Digital Currencies

Altcoin season 2.0: why bitcoin has been outgunned by crypto rivals since new year

 

Altcoin season 2.0: why bitcoin has been outgunned by crypto rivals since new year

‘We have you surrounded!’ Wit Olszewski

Courtesy of Gavin Brown, Manchester Metropolitan University and Richard Whittle, Manchester Metropolitan University

When bitcoin was trading at the dizzying heights of almost US$2...



more from Bitcoin

ValueWalk

What US companies are saying about coronavirus impact

By Aman Jain. Originally published at ValueWalk.

With the coronavirus outbreak coinciding with the U.S. earnings seasons, it is only normal to expect companies to talk about this deadly virus in their earnings conference calls. In fact, many major U.S. companies not only talked about coronavirus, but also warned about its potential impact on their financial numbers.

Q4 2019 hedge fund letters, conferences and more

Coronavirus impact: many US companies unclear

According to ...



more from ValueWalk

Chart School

RTT browsing latest..

Courtesy of Read the Ticker

Please review a collection of WWW browsing results. The information here is delayed by a few months, members get the most recent content.



Date Found: Tuesday, 01 October 2019, 02:18:22 AM

Click for popup. Clear your browser cache if image is not showing.


Comment: Wall of worry, or cliff of despair!



Date Found: Tuesday, 01 October 2019, 06:54:30 AM

Click for popup. Clear your browser cache if image is not showing.


Comment: Interesting.. Hitler good for the German DAX when he was winning! They believed .. until th...



more from Chart School

Lee's Free Thinking

Why Blaming the Repo Market is Like Blaming the Australian Bush Fires

 

Why Blaming the Repo Market is Like Blaming the Australian Bush Fires

Courtesy of  

The repo market problem isn’t the problem. It’s a sideshow, a diversion, and a joke. It’s a symptom of the problem.

Today, I got a note from Liquidity Trader subscriber David, a professional investor, and it got me to thinking. Here’s what David wrote:

Lee,

The ‘experts’ I hear from keep saying that once 300B more in reserves have ...



more from Lee

Mapping The Market

How IPOs Are Priced

Via Jean Luc 

Funny but probably true:

...

more from M.T.M.

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. Contact Ilene to learn about our affiliate and content sharing programs.